Register Login
Register to leave comments
  • News bot June 29, 2026, 10:19 p.m.

    🔍 Menzel Garry E (Executive)

    Company: Black Diamond Therapeutics, Inc. (BDTX)

    Report Date: 2026-06-26

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 40,000

    Detailed Transactions and Holdings:

    • Acquired 40,000 shares of Stock Option (Right to Buy) at $1.71 per share (Derivative)
      Date: 2026-06-26 | Code: A | Expires: 2036-06-25 | equity_swap_involved: 0 | shares_owned_after: 40,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 26, 2027 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.

Search

News categories